Stephan Rauscher

Founded in 1997, Earlybird identifies and backs exceptional early-stage companies on a pan-European basis – supporting them through their growth and development phases and providing financial resources, strategic support, plus access to an international network and capital markets. Through two separate strategies, Earlybird focuses on tech-enabled businesses in fintech/insurtech, enterprise software, and deep tech (energy, food, and space) while Earlybird Health focuses on improving patient outcomes. Earlybird additionally has a Growth Opportunity Fund for follow-on investments, and a pro-bono impact initiative, Vision Lab. With EUR 2.5 billion under management across fund streams and a history of 9 IPOs and 35 trade sales, Earlybird is among Europe’s most established and active venture capital firms.